IRVINE, Calif., August 1, 2023 (Newswire.com)
-
MOZA Technology, the cutting-edge health brand born from American and China team innovation, celebrates a triumphant global crowdfunding campaign. With overwhelming support from thousands of backers, MOZA RoboHands' revolutionary 4D massage experience has won worldwide acclaim.
Since its launch on Kickstarter in June, MOZA RoboHands has exceeded expectations, resonating with a world grappling with post-pandemic economic strain and mental health challenges. MOZA's vision of "Back to life" has struck a chord, empowering individuals to rediscover their health and well-being, living in the moment and embracing self-care.
Fueled by the staggering statistics from the World Health Organization (WHO) showing over 350 million people worldwide affected by depression, MOZA addresses the pressing need for healing solutions. By integrating psychology into rehabilitation through modern technology, MOZA's groundbreaking methods encompass massage therapy, aromatherapy, hot stone therapy, light therapy, and mindfulness. Their patented MOZA Superpower™ spin massage, combined with aromatic oils, reaches deep into muscles, relieving pain, anxiety, and stress - bringing people "Back to life" in just 10 minutes.
"The support from our backers is truly humbling, and it inspires us to push further," says MOZA's founder, Morgan Chen. "We will continue to explore rehabilitation medicine and psychology, creating user-friendly, portable solutions that harness technology to elevate the quality of life, helping people find their way 'Back to life' in just 10 minutes."
Exciting developments are ahead, and MOZA will usher in a major renovation of the official website in August. It will showcase the much-anticipated MOZA brand content and exhilarating product activities.
Additionally, MOZA proudly announces the imminent arrival of a Mysterious new product. Embodying the essence of "Back to life," this Kickstarter innovation promises groundbreaking mind-body healing solutions.
HAUPPAUGE, N.Y., August 1, 2023 (Newswire.com)
-
Orthoscan announced the End of Life (EOL) plan for its Orthoscan FD, FD-OR, Mobile DI (MDI), and FD Pulse Mini C-Arms. The following Mini C-Arms are scheduled to reach their EOL on the specified dates below. The EOL designation signifies that these machines have served their purpose diligently, yet due to various reasons, such as the discontinuation of component technology or the lack of ongoing support from raw material suppliers, their life cycle is coming to a close.
Despite the End of Life (EOL) status of Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms, Minicarm.com remains steadfast in its commitment to support these machines. With a vast inventory of parts and machines, coupled with extensive experience in the industry, Minicarm.com stands as a reliable partner for all service, sales, and parts requirements. Our unwavering dedication ensures that customers can still rely on us to keep their Mini C-Arms operating at peak performance, extending their useful life and maximizing their value. At Minicarm.com, we believe in providing unparalleled support, even for products with an EOL designation, ensuring that our customers' needs are met with the utmost care and professionalism.
About Minicarm.com
At Minicarm.com, we proudly hold the leading position in the industry for refurbished Mini C-Arm fluoroscopy sales, service, parts and rentals. As a pioneering entity, Mini C Arm LLC specializes in remanufacturing Mini C-Arm machines crafted by manufacturers such as Hologic, OEC, and Orthoscan, meticulously restoring them to pristine conditions that mirror their original state. These reinvigorated machines are made available for purchase or rental to medical facilities, including clinics, hospitals, surgery centers, and Doctors' offices nationwide and around the globe. Notably, our President, Christopher Bacon, stands as the technical founder of Orthoscan, a prominent Mini C-Arm manufacturer, adding an extra layer of expertise and credibility to our operations. With our unwavering dedication to quality and innovation, Minicarm.com continues to set the benchmark for excellence in the industry.
The CPR training center at 535 Main Street, Suite 307, Martinez, CA 94553, is centrally located near Concord. The location serves medical and healthcare professionals in Contra Costa County who do not want to drive into Concord for a certification course. This new office offers a flexible schedule of daily and weekend classes to meet the needs of busy professionals.
Safety Training Seminars' training programs in Martinez include new and renewal certification courses in CPR, BLS, ACLS, and PALS. Each class offers a flexible blend of online learning components and on-site skills testing.
ACLS Courses offer initial and renewal certification in Advanced Cardiovascular Life Support. Attendees learn about continuous, high-quality CPR and how to administer it correctly. The program is designed for professionals responding to cardiopulmonary arrest or other cardiovascular emergencies.
CPR & First-Aid Classes are designed for a wide variety of participants who may respond to emergencies, including teachers, coaches, supervisors, and others. The course covers CPR, choke saving, AED use, bleeding treatment, seizures, and more. Students will receive the American Heart Association CPR and First-Aid certification after the course. This course is valid for California childcare providers.
BLS CPR Certification courses are offered for new or renewal certification. They help attendees identify and respond to life-threatening emergencies, properly administer chest compressions, perform ventilation, and AED use.
PALS Courses are designed for those working in emergency response, emergency medicine, intensive care, and critical care units. Each course is designed to meet the criteria for initial or renewal certification. Pediatric Advanced Life Support courses help attendees recognize emergencies and administer lifesaving treatments in infants and children.
"An emergency situation can arise at any time, and our goal is to equip as many Contra Costa County residents as possible with the lifesaving skills and confidence to react when seconds count," said Laura Seidel, owner, Safety Training Seminars.
Anyone looking for an American Heart Association course in Northern California should look no further than Safety Training Seminars. With CPR classes offered every day in 42 Northern California cities, Safety Training Seminars is the go-to for CPR, BLS, ACLS, PALS, NRP, and First-Aid courses. All courses are taught by experienced and certified professionals, and are certified by the American Heart Association. For large groups, Safety Training Seminars offers group classes and discounts. With over 50,000 people trained each year and an impressive 4.86 satisfaction rating, Safety Training Seminars is the perfect choice for your next American Heart Association course.
Contact Information:
Danielle Bell
General Manager [email protected]
415-437-1600
New York's Leading Food & Music Festival Featuring 35+ of the World's Greatest Pizzerias, Including Lucali, Sally's Apizza, Patsy's, Prince Street, John's of Bleecker, Di Fara, DeLorenzo's Tomato Pies, Frank Pepe Pizzeria, and Angelo's of Philly, Plus Live Performances From Teddy Swims, DJ Irie, and Pup Punk
Ticket Pre-Sale: Friday, Aug. 4, at 10 a.m. ET
All-Inclusive Pizza Tickets Begin at $149.99 — Register Now
NEW YORK, August 1, 2023 (Newswire.com)
-
Barstool Sports founder and legendary pizza aficionado Dave Portnoy announces his first-ever food and music festival: Dave Portnoy's One Bite Pizza Festival. Together with Portnoy, Medium Rare will bring Dave's over-the-top, pizza-loving personality to life for the inaugural One Bite Pizza Festival that will welcome 5,000+ pizza-loving fans to Maimonides Park, home of the Brooklyn Cyclones, to experience the greatest gathering of pizzerias ever, interactive pizza experiences and main stage performances. Interested in attending this culinary Mecca of Pizza? All-inclusive all-you-can-eat pizza tickets begin at $149.99 and will offer fans unprecedented access to the world's best pizzerias. Tickets will be available starting Friday, Aug. 4, at www.onebitepizzafest.com. Make sure to register for the pre-sale now to lock in the best pricing.
Featuring Dave's top-rated One Bite Pizzerias, fans will experience the greatest gathering of pizzerias ever: Lucali, Sally's Apizza, Patsy's Pizzeria, Prince Street Pizza, John's of Bleecker Street, DeLorenzo's Tomato Pies, Di Fara Pizza, Frank Pepe Pizzeria, Napoletana, Angelo's Pizzeria South Philly, and 25+ more. Pizzerias will be popping up and serving all-you-can-eat pizza at the festival, with interactive dining experiences bringing their iconic brands to life like never before, plus all fans will receive complimentary access to an Italian Dessert Village featuring NYC favorites: The Lemon Ice King, Ferrara Bakery, Sal & Jerry's Bakery, and Caffè Arrone.
At One Bite Pizza Festival, fans will get more than a taste of pizza and enjoy main stage performances from musical superstar Teddy Swims, Barstool favorite Pup Punk, DJ Irie, and more. Also, in a soon-to-be-viral moment, festival attendees will experience Dave Portnoy's first-ever One Bite Live on the festival's main stage … you know the rules.
"After touring America reviewing thousands of pizzerias throughout the country in search of the perfect slice, I am beyond excited to gather my favorite pizzerias at the inaugural One Bite Festival. New York City's most exciting new food festival will feature 35+ iconic pizzerias, main stage performances from my guys Teddy Swims and Pup Punk, and unprecedented interactive pizza experiences. Don't sleep on these tickets before they all sell out … One Bite Everyone Knows The Rules," said Dave Portnoy.
One Bite Pizza Festival is poised to be one of New York's hottest culinary experiences, taking place annually in Brooklyn as well as popping up in cities around the country. With only 5,000 tickets available for purchase, this exclusive festival will include all-you-can-eat pizza from 35+ iconic pizzerias, Dave Portnoy-curated concepts, superstar musical performances, cocktails and cold beer available for purchase, all alongside Dave's first-ever One Bite Live. One Bite Festival is selling a limited number of passes to the festival — all tickets will sell out. Tickets will increase in price as the festival weekend approaches, so the earlier you purchase tickets, the more money you will save. Presale tickets go on sale this Friday, Aug. 4, at 10 a.m. ET starting at $149.99. Make sure to register for the pre-sale now to lock in the best pricing. VIP All-Inclusive Pizza & Open Bar Tickets will also be available for fans 21+.
Peanut butter … and whiskey? Yes, that's right. This harmonious blend might seem a bit unexpected, but it's a whole lot of delicious. Skrewball Peanut Butter Whiskey is excited to partner with One Bite Pizza Festival to give fans a taste of its signature cocktails and say cheers to the misfits, black sheep, and Skrewballs in attendance.
High Noon will be bringing its #1 Best Tasting Hard Seltzer* to the One Bite Festival grounds this fall. Look for Dave Portnoy's favorite hard seltzer made with Real Vodka & Real Juice which will be for sale throughout the grounds for fans 21+. High Noon Hard Seltzer is 100 calories, gluten-free, has no added sugar and comes in over 17 delicious flavors. High Noon. Sun's Up! *Source: The Tasting Panel, January 2021. Rated via blind tasting of industry professionals.
As an official partner of One Bite Pizza Festival, ZYN Nicotine Pouches are a fresh way to enjoy nicotine. Adult tobacco and nicotine consumers (21+ only) are invited to visit the ZYN Experience. Find Your ZYN.
Zamora Company, the famed, 100% family-owned Spanish company is excited to bring brands from its iconic spirits family to One Bite Pizza Festival. Featuring Licor 43, Lolea Sangria, and Martin Miller's Gin for sale at all festival bars, Zamora Company will enable 21+ fans to sip on delectable creations from the Licor 43 Carajillo to the classic Martin Miller's gin and tonic — the perfect complements to any slice.
C4 Energy,The Official Energy Drink of One Bite Pizza Festival, is here to supercharge your experience with free samples for VIP guests and a dedicated C4 bar to provide ALL pizza-loving enthusiasts with the ultimate fan experience. Don't forget to pick up a can of C4 at your local Stop & Shop, 7-Eleven or Bolla Market before the event because remember, it's ONE SIP EVERYBODY KNOWS THE RULES.
PizzaMaster®U.S. distributor MPM Food Equipment Group is thrilled to provide world-class PizzaMaster electric deck ovens to some of One Bite Pizza Festival's most iconic pizzerias. PizzaMaster offers the largest electric deck oven range in the world with 85+ sizes, 1,500+ models, and more than one million combinations to meet each pizza shop's unique needs. The brand's high-power and high-temperature ovens will provide superior capacity and versatility, and an old-world bake flavor for the tastiest pizza. Everyone will want more than just one bite of the pizzas crafted in a PizzaMaster oven.
Marra Forni,the official brick oven of the One Bite Pizza Festival, is best known for its innovation, customization, and quality. Together with Marra Forni, some of One Bite's greatest pizzerias will have the ability to fire up their pizzas on the best wood and coal-fired pizza ovens in the business.
Lauded events, experiential, and management company Medium Rare works at the intersection of Sports & Entertainment, partnering with well-known athletes and brands to create iconic media properties, including Shaquille O'Neal's Fun House, Daymond John's Black Entrepreneurs Day, Guy Fieri's Restaurant Reboot, Travis Kelce's Kelce Jam, Rob Gronkowski's Gronk Beach, and more. Creating and executing iconic IP and events that draw in millions of views and fans from around the world, Medium Rare also reaps industry accolades. Recognized with six Webby Awards, Medium Rare founders Joe Silberzweig and Adam Richman are Forbes 30 Under 30 alumni and have graced the Pollstar Next Gen and Variety New Leaders lists in 2020 and 2021, respectively. The group's world-class production is balanced by its growing management division, overseeing careers, tours, and partnership deals for some of the most celebrated artists and athletes, including Gordo (formerly DJ Carnage), DJ Diesel aka SHAQ and Rob Gronkowski. For more info, visit www.Medium-Rare.com.
Happy Head and Its Dermatologists Have Developed a First-of-Its-Kind Hair Growth Topical Cream Infused With Finasteride and Minoxidil
LOS ANGELES, August 1, 2023 (Newswire.com)
-
Happy Head today announces the launch of its newest innovation in topical hair growth solutions. Designed by dermatologists and hair restoration experts, this formula infuses the strongest prescription-grade hair growth medicine into a liposomal base which gradually releases the medication into hair follicles and reduces systemic absorption and potential side effects. Its the first product of its kind to use FDA-approved ingredients in a lipid-based, mess-free formula.
Happy Head's Topical Finasteride and Minoxidil (Liposomal Formula) is a daily-use product designed to make treating hair loss easy. No gel, spray or other topicals have been able to achieve this level of treatment. Dermatologists say three to six months of Topical Finasteride and Minoxidil (Liposomal Formula) use will not only help regrow lost hair, but prevent further hair loss.
Hair loss causes intense psychological distress. Over two-thirds of men experience hair loss by the age of 35, but it's not just men. Over 40 percent of Americans who experience hair loss are women.
Because hair loss affects so many people, the cosmetic industry has been hard at work producing solutions to address the problem of hair loss. Combining Minoxidil and Finasteride in one convenient topical formula will provide customers with an even more powerful solution with a lower risk of side effects.
"Our liposomal formula is a game changer in the hair industry because it can potentially reduce the systemic absorption of Finasteride. This translates to a lower risk of sexual side effects from Finasteride. Many patients avoid using Finasteride because of the potential side effects. Finasteride inhibits the DHT formation, mainly affecting scalp DHT and not serum DHT (the real benefit is that serum DHT and serum Testosterone are left unaffected). Our topical also includes Minoxidil, which is unique because most liposomal formulas do not. So we're not only reducing the effect on systemic absorption, but also increasing blood flow to the scalp, which will allow for better hair growth," said Dr. Ben Behnam, M.D., FAAD, and co-founder of Happy Head.
This totally new hair growth solution isn't offered by any other brand. The product comes in a 30 ml bottle and will last for one month. It costs $179 per month and is delivered straight to the customer's door.
About Happy Head
Happy Head is a telemedicine provider of dermatologist-prescribed, customized hair medicine and treatments. Founded in 2021, Happy Head specializes in customized formulas to prevent and treat hair loss in both men and women. Happy Head products are backed by some of the best dermatologists and hair restoration experts in the industry. The company hopes to help people who struggle with hair loss to not only regrow their hair, but also regain their confidence and sense of self that is sometimes caused by hair loss.
Aster Springs expands its continuum of care in Nashville, Tennessee with residential services supporting a full spectrum of eating disorders for adult women.
BRENTWOOD, Tenn., August 1, 2023 (Newswire.com)
-
Odyssey Behavioral Healthcare, a leading provider of eating disorder, mental health, and addiction treatment services, proudly announces the opening of the newest Aster Springs residential eating disorder treatment facility, licensed by the TN Department of Mental Health and Substance Abuse Services, in Nashville, Tennessee. Located minutes from downtown Music City, the latest addition to the Aster Springs residential treatment family underscores Odyssey's continued commitment to growth to address unmet demand. Aster Springs provides residential and outpatient treatment services in Indiana, Kentucky, Ohio, Tennessee, and Virginia and is their second location in Nashville, along with their Aster Springs Outpatient - Nashville clinic.
According to recent reports from the National Association of Anorexia Nervosa and Associated Disorders (ANAD):
28.8 million Americans will have an eating disorder in their lifetime.
10,200 deaths each year are the direct result of an eating disorder.
Eating disorders are among the deadliest mental illnesses, second only to opioid overdoses.
"The need for eating disorder treatment at all levels of care continues to grow nationally for individuals with these complex conditions," said Richard Clark, CEO of Odyssey Behavioral Healthcare. "Odyssey is addressing Tennessee's underserved demand by opening additional residential services in Nashville. This new facility also strengthens Odyssey's growing national network of eating disorder residential and outpatient treatment services that provide quality care for those in need."
Aster Springs is known for their whole-person approach to treatment, low client-to-clinician ratio, and unique, home-like settings. The Aster Springs residential treatment facility in Nashville cares for adult women with an eating disorder through a residential treatment program (RTC) and a partial hospitalization program (PHP). As a transformed songwriter's retreat, the facility's peaceful surroundings offer an idyllic environment and a small community for healing.
"Aster Springs is recognized as a leading treatment program with residential and outpatient programs in five states," said Chrissy Hall, LCSW, Group CEO of Aster Springs. "Our clinical and support teams are some of the best in the industry. I'm proud to expand our proven combination of compassionate care and evidence-based approaches to more individuals in need with the addition of our newest Nashville, Tennessee location."
Odyssey, formed in 2015, has a diverse clinical network of services treating adults and adolescents for eating disorders, psychiatric disorders, dual diagnosis, and other addictive disorders. Odyssey provides a continuum of care within our Psychiatric Network and Eating Disorder Network, including inpatient, intensive residential, partial hospitalization, outpatient services, detoxification, and transitional living at over 35 locations and affiliated Odyssey Outpatient Network clinics in nine states with over 600 beds.
A new image from Saw X, the tenth film in the Saw franchise, shows Shawnee Smith, reprising the role of Amanda Young
The trailer for the new film in the Saw franchise – which is going by the title Saw X since it’s the tenth installment – arrived online over the weekend, giving a preview of this story that’s set between the events of the first Saw and Saw II. Now a new image from the film has been unveiled, giving a look at a character who is able to return to the series because of its place in the timeline: Amanda Young, played by Shawnee Smith! The image can be seen at the bottom of this article. Saw X is set to reach theatres on September 29th.
Amanda was previously seen in Saw, Saw II,Saw III, and Saw VI. The character didn’t make it out of III alive (and neither did John “Jigsaw” Kramer).
Saw VI and Saw: The Final Chapter director Kevin Greutert (who also edited the first five films, plus Jigsaw) is back at the helm for Saw X. Jigsaw and Spiral: From the Book of Saw screenwriters Pete Goldfinger and Josh Stolberg have written the script. Stolberg has promised that this movie “is gonna make John Kramer fans very happy!” It has been said that “The upcoming Saw movie is planned to be very much a John Kramer story … The idea is that the story is being told from Kramer’s point of view as opposed to following the trap victims.”
Here’s the synopsis: In the Twisted Pictures next installment John Kramer (Tobin Bell) is back, and it’s the untold chapter of Jigsaw’s final games. Set between the events of Saw I and II, a sick and desperate John travels to Mexico for a risky and experimental medical procedure in hopes of a miracle cure for his cancer – only to discover the entire operation is a scam to defraud the most vulnerable. The infamous serial killer returns to his work, turning the tables on the con artists in his signature visceral way through devious, deranged, and ingenious traps.
Tobin Bell reprises the role of John Kramer / Jigsaw and is joined in the cast by Synnøve Macody Lund (Ragnarok), Steven Brand (The Sandman), Michael Beach (Dahmer – Monster: The Jeffrey Dahmer Story), Renata Vaca (Pedal to Medal), Paulette Hernandez (Crown of Tears), Joshua Okamoto (Control-Z), Octavio Hinojosa (How to Survive Being Single), and Smith.
Franchise producers Mark Burg and Oren Koules of Twisted Pictures provided the following statement: “What a thrill to be reuniting with Tobin. His performance as John Kramer is part of the magic that made this franchise a phenomenon and his character is an active part of this film.” They have previously said, “We have been listening to what the fans have been asking for and are hard at work planning a movie that Saw aficionados and horror fans alike will love.”
A press release from Lionsgate says “the return of Bell to the franchise furthers Lionsgate and Twisted Pictures’ goal of a film that captures everything Saw fans love about the franchise, while also keeping them guessing with all-new traps and a new mystery to solve.”
Deadline reminds us that Bell’s Kramer (otherwise known as Jigsaw) is “the antagonist at the heart of the Saw franchise – a former civil engineer who was diagnosed with colon cancer and subsequently elected to test others’ will to live via a series of deadly games. The character appeared in the first three Saw films before being killed off, then going on to appear via flashbacks in most of the films that followed.”
Are you looking forward to Saw X, and are you glad to see Shawnee Smith back in the role of Amanda Young? Share your thoughts on this one by leaving a comment below.
Carebox to help LCRF advance lung cancer research by making it easier and more effective for patients, caregivers and healthcare professionals to identify relevant lung cancer trials.
NEW YORK and RALEIGH, N.C., August 1, 2023 (Newswire.com)
-
Carebox, a leading provider of clinical trial matching solutions, and the Lung Cancer Research Foundation (LCRF), a leading nonprofit organization focused on research to extend survival and improve quality of life for people with lung cancer, today announced the launch of a Carebox Connect experience optimized for lung cancer patients.
From the clinical trials page of the LCRF website, lung cancer patients, their caregivers and healthcare professionals can visit the Carebox Connect web application for an easy and effective way to search for and match to potentially relevant trials. By making this search resource available on its website, LCRF is connecting patients to research and enabling them to make the best treatment decisions for themselves.
Visitors to the web application can complete a 10-question questionnaire about the patient's lung cancer condition and then instantly see which of over 1,000 actively recruiting clinical trials with treatment options are potentially relevant for them. They can then get connected to a trial research site for next steps.
The Carebox Connect trial database is synchronized daily with the ClinicalTrials.gov clinical trial data maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Applying its human-supervised AI, Carebox converts the unstructured text in ClinicalTrials.gov that describes eligibility criteria for enrollment into a searchable index of clinical criteria for matching with patient characteristics.
"Carebox Connect enables us to both advance research and make clinical trial treatment options much more accessible to the lung cancer patient community." -Aubrey Rhodes, Executive Director of LCRF
For more advanced users, full search and filtering capabilities are available. Filters can be saved for future use. Furthermore, based on those saved filters, users can subscribe to receive Carebox Connect notifications in their email inbox whenever new trials open (or new sites open) in a defined distance radius from where they are located.
"LCRF is on a mission to improve lung cancer outcomes by funding research for prevention, diagnosis, treatment and cure. Patient participation in clinical trials is a critical component on the road to our vision of a world free of lung cancer," explains Aubrey Rhodes, Executive Director of LCRF, adding that "Carebox Connect enables us to both advance research and make clinical trial treatment options much more accessible to the lung cancer patient community."
"The Carebox Connect Network has a common technology foundation and a unified end-user application," notes Assaf Levi, Carebox VP of R&D. "However, we can create customized experiences for each specific condition so that lung cancer patients arriving from LCRF are directed to the relevant questionnaire and trials for them. Knowing that we are touching the lives of so many patients and can help support efforts of organizations like LCRF in advancing such important research, is core to what makes working at Carebox special for the entire engineering team."
About the Lung Cancer Research Foundation
The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF's mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. To date, LCRF has funded 409 research grants, totaling nearly $42 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. For more information, visit LCRF.org.
About Carebox
Carebox connects patients and physicians seeking treatment options with clinical trials. For patients and families, access to information about the newest and most advanced treatment options is obscured and frustrating to find. For pharma companies, clinical trial recruitment is the primary bottleneck in the $100B+ drug development market now being reshaped by precision medicine treatment specificity, new trial models, diversity requirements, and digital health consumer expectations. Carebox is at the forefront of addressing these challenges for patients and their families, as well as for the ecosystem of companies involved in sponsoring, running, and recruiting for clinical trials.
The Carebox Connect cloud platform digitizes Carebox's two decades of experience in navigating over one million patients seeking clinical trial options. It enables trial sponsors of all sizes to educate, engage, navigate, match, qualify, refer, and enroll patients in their clinical trials. Pharma trial sponsors, hospital research centers, and patient advocacy groups use Carebox Connect to present their clinical trial portfolios to the public, optimize trial recruitment, and enhance participant diversity in support of ongoing clinical research.
About The Carebox Connect Network
In addition to customer-branded Carebox Connect solutions for trials sponsors and sites, the Carebox Connect Network brings the power of the platform to patients, families, and caregivers via a rapidly growing network of dozens of patient advocacy groups and physician associations reaching tens of thousands of patients. Carebox runs co-branded and branded web applications and/or clinical trial navigation services on behalf of its Carebox Connect Network partners.
Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats.
SARASOTA, Fla., August 1, 2023 (Newswire.com)
-
The acclaimed Essex Cardiothoracic Centre, part of Mid and South Essex NHS Foundation Trust, was recognized with an award following their cutting-edge clinical study that evaluated a novel groin closure method to allow rapid same-day discharge following atrial fibrillation (AF) ablation procedures to treat patients with irregular heartbeats.
The study evaluated using the StatSeal® Advanced Plus Disc (Biolife, LLC) for femoral vein groin closure of AF ablation patients who remained on their anticoagulation medications. The previous closure method used was physician-placed sutures. During the study, 50 AF ablations were performed, and StatSeal Advanced Plus Disc was applied to the groin closure site by technicians, not the physicians, with only 5 to 10 minutes of manual pressure. The median recovery time for the StatSeal group was just 2 hours, compared to 4 hours with the suture closure method. The median discharge time for the StatSeal group was only 2.5 hours, compared to 5 hours with the suture closure method. StatSeal use resulted in a more than 50% decrease in recovery time, with no rise in complications, allowing patients to safely mobilize and get home earlier compared to the suture closure method. The study concluded that StatSeal use will likely lead to increased same-day discharge and fewer overnight stays following AF ablations.
As a result of this study, which demonstrates the efficacy of StatSeal use for groin closure, the Essex Cardiothoracic Centre has been recognized globally as a Centre of Excellence for Atrial Fibrillation by the Atrial Fibrillation Association. The study was published in the 2023 AF Healthcare Pioneer Report, which can be found online at: https://api.heartrhythmalliance.org/files/download/621e9388e8269ecaa50c07a133797450
Lead investigator Rhoel Peralta, Cath Lab Associate Practitioner at MSE Hospitals, commented, "Our efforts and success prove that we can all play our part for patients and make a difference, and this acknowledgment reinforces our commitment to providing exceptional care to our patients. We are thrilled to be recognized as a Centre of Excellence and AF Healthcare Pioneers. I am part of a much larger team where everyone came together and worked tirelessly."
Biolife, LLC
Biolife, LLC is a privately-owned medical device company headquartered in Sarasota, Florida, that manufactures innovative healthcare and first aid solutions that stop bleeding fast and improve patient outcomes. All Biolife products are comprised of a powder with two main ingredients: potassium ferrate and a hydrophilic polymer. The products work independently of the clotting cascade to seal the wound or procedural site, while accelerating hemostasis. The low pH seal created by the powder helps reduce risk of infection and helps improve recovery time. StatSeal® products for the healthcare industry are available in powder and disc (compressed powder) form to suit a wide variety of clinical applications. For more information, visit: https://www.biolife.com/
Contact Information:
Angela Augustitus
Director of Marketing [email protected]
+1 941 360 1300 X117
BELLEVUE, Wash., August 1, 2023 (Newswire.com)
-
Bellevue, Washington-based mental wellness center THIRA Health is excited to announce the launch of its Adolescent Residential Treatment Program that aims to help 13- to 17-year-olds struggling with anxiety, depression, and self-harm and trauma-related disorders.
The adolescent residential treatment program is built upon creative, innovative, and actionable ways of navigating treatment. With a team of experienced practitioners, this program offers round-the-clock guidance on DBT (Dialectical Behaviour Therapy) onboarding to support participants on their journey as they build coping skills that can cultivate long-term, meaningful life changes.
The program also includes a series of unique support such as:
Individualized family engagement sessions
Weekly multi-family skills training reviews
Individual therapy sessions with a DBT-trained therapist
Comprehensive nutrition program which will be overseen by Registered Dieticians
Daily emotional and physical health support by registered nurses and certified nursing assistants
Psychiatric medication with a team of psychiatrists and expert nurse prescribers
Expressive Arts with registered art therapists
Academics with a certified teacher
Mindfulness groups (including mindful movement, yoga, and qigong)
Therapeutic outings, equine-assisted learning, and volunteering to foster participants' sense of connection and belongingness
THIRA Health is led by a team of experts with collective experience exceeding 100 years and a dedication to helping people strive for a life worth living. Dr. Mehri Moore is our founder and Dr. Kathryn Korslund is our CEO — both doctors guide a team of 100+ clinical and support staff.
THIRA Health provides services ranging from residential for adolescents to intensive outpatient for ages 13+. Our commitment to the rigor of Dialectical Behaviour Therapy combined with innovative supportive treatments and medication management ensures top-tier treatment for women, teen girls and gender non-conforming individuals.
Contact Information:
Sarah Skoterro
Director of Business Development [email protected]
206-718-0866
